Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
Clinical trial NCT03572036 · COMPLETED
Trial details
- NCT number
- NCT03572036
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-20
- Primary completion
- 2021-04-16
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.